Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Nadia Solovieff

Showing results (21-30 of 32) with videos related to

Pageof 4
Sort By:
Plos One|January 27, 2012
Genetic signatures of exceptional longevity in humansPaola Sebastiani, Nadia Solovieff, Andrew T Dewan, et al.
JCO Precision Oncology|September 10, 2021
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and RibociclibAditya Bardia, Fei Su, Nadia Solovieff, et al.
Blood|December 19, 2009
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene clusterNadia Solovieff, Jacqueline N Milton, Stephen W Hartley, et al.
American Journal of Hematology|May 30, 2012
A functional promoter polymorphism of the δ-globin gene is a specific marker of the Arab-Indian haplotypeAbdulrahman Alsultan, Duyen A Ngo, John J Farrell, et al.
Blood Cells, Molecules & Diseases|March 8, 2013
Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotypeDuyen Ngo, Harold Bae, Martin H Steinberg, et al.
Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical TrialYen-Shen Lu, Seock-Ah Im, Marco Colleoni, et al.
Plos One|December 17, 2009
RNA editing genes associated with extreme old age in humans and with lifespan in C. elegansPaola Sebastiani, Monty Montano, Annibale Puca, et al.
Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.
Nature|January 28, 2014
A polygenic burden of rare disruptive mutations in schizophreniaShaun M Purcell, Jennifer L Moran, Menachem Fromer, et al.
Pageof 4

Showing results (21-30 of 32) with videos related to

Sort By:
Pageof 4
Plos One|January 27, 2012
Genetic signatures of exceptional longevity in humansPaola Sebastiani, Nadia Solovieff, Andrew T Dewan, et al.
JCO Precision Oncology|September 10, 2021
Genomic Profiling of Premenopausal HR+ and HER2- Metastatic Breast Cancer by Circulating Tumor DNA and Association of Genetic Alterations With Therapeutic Response to Endocrine Therapy and RibociclibAditya Bardia, Fei Su, Nadia Solovieff, et al.
Blood|December 19, 2009
Fetal hemoglobin in sickle cell anemia: genome-wide association studies suggest a regulatory region in the 5' olfactory receptor gene clusterNadia Solovieff, Jacqueline N Milton, Stephen W Hartley, et al.
American Journal of Hematology|May 30, 2012
A functional promoter polymorphism of the δ-globin gene is a specific marker of the Arab-Indian haplotypeAbdulrahman Alsultan, Duyen A Ngo, John J Farrell, et al.
Blood Cells, Molecules & Diseases|March 8, 2013
Fetal hemoglobin in sickle cell anemia: genetic studies of the Arab-Indian haplotypeDuyen Ngo, Harold Bae, Martin H Steinberg, et al.
Plos One|May 5, 2012
A genome-wide association study of total bilirubin and cholelithiasis risk in sickle cell anemiaJacqueline N Milton, Paola Sebastiani, Nadia Solovieff, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 30, 2021
Updated Overall Survival of Ribociclib plus Endocrine Therapy versus Endocrine Therapy Alone in Pre- and Perimenopausal Patients with HR+/HER2- Advanced Breast Cancer in MONALEESA-7: A Phase III Randomized Clinical TrialYen-Shen Lu, Seock-Ah Im, Marco Colleoni, et al.
Plos One|December 17, 2009
RNA editing genes associated with extreme old age in humans and with lifespan in C. elegansPaola Sebastiani, Monty Montano, Annibale Puca, et al.
Nature Communications|March 28, 2019
Aberrant FGFR signaling mediates resistance to CDK4/6 inhibitors in ER+ breast cancerLuigi Formisano, Yao Lu, Alberto Servetto, et al.
Nature|January 28, 2014
A polygenic burden of rare disruptive mutations in schizophreniaShaun M Purcell, Jennifer L Moran, Menachem Fromer, et al.
Pageof 4